Global Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

Global Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

The global Transcriptome Sequencing market size is projected to grow from US$ 1883.6 million in 2022 to US$ 5713.9 million in 2029; it is expected to grow at a CAGR of 17.2% from 2023 to 2029.

The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The global transcriptome sequencing service providers are mainly distributed in North America, Europe, China and Japan, among which the market share of the top three regions is close to 80%. At present, North America is the largest service provider region. In terms of its service type, the growth rate of noncoding RNA is relatively fast. At present, the market share of coding RNA is high, close to 80%. In terms of its application, biomedicine is the largest application field, with a market share of more than 85%, followed by non-medical fields.

LPI (LP Information)' newest research report, the “Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Transcriptome Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Transcriptome Sequencing sales for 2023 through 2029. With Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcriptome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcriptome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcriptome Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcriptome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcriptome Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Coding RNA
Noncoding RNA

Segmentation by application
Biomedical Field
Non-medical Field

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.